Neurodegeneration Risk
topic
Chronic sleep deprivation is associated with elevated risk of neurodegenerative disease — particularly Alzheimer's disease — through the mechanism of impaired glymphatic clearance of amyloid-beta and tau proteins, with epidemiological data showing that people reporting regular sleep under 6 hours in midlife have approximately 30% higher Alzheimer's risk in later life, independent of other risk factors. The relationship appears to be bidirectional: Alzheimer's pathology disrupts sleep, and disrupted sleep accelerates Alzheimer's pathology.
Role
The Alzheimer's-sleep connection is perhaps the most important long-term health implication of sleep deprivation for a population that will, for the first time in history, routinely survive long enough to be at significant dementia risk. The nightly glymphatic flush of amyloid-beta is not a metaphor — it is a measurable physiological process whose insufficiency produces measurable protein accumulation that is the defining pathological feature of Alzheimer's disease. Treating sleep deprivation as a benign productivity trade-off ignores its status as one of the most modifiable risk factors for the most feared disease of old age.